Skip to main
TVGN

TVGN Stock Forecast & Price Target

TVGN Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Tevogen Bio Holdings is currently making significant strides in advancing their ExacTcell platform across various fields, including virology, oncology, and neurology. This is supported by their recent investment in Tevogen.AI and their indication of evaluating further life sciences-related transactions, indicating a desire to build an integrated and scalable healthcare enterprise. However, the recent decline in their share price has potentially impacted their capital formation and balance sheet flexibility, leading us to increase our dilution assumptions and push out our commercialization timeline to 2029. This in turn brings potential risks including clinical/regulatory, partnership and financial, commercial, legal and intellectual property, and market share risks.

Bears say

Tevogen Bio Holdings is facing significant challenges that could hinder its future success and growth. The announcement of a reverse stock split has caused negative sentiment among retail investors and could result in reduced liquidity and a shrinking shareholder base. While the potential acquisition of a contract research organization could improve the company's operational control and earnings visibility, it is not guaranteed and no assurance of completion. Overall, the company's dilution risk, delayed commercialization timeline, and potential difficulties in advancing its ExacTcell platform could impact its stock negatively and make it a risky investment option.

TVGN has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Semper Paratus Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Semper Paratus Acquisition Corp (TVGN) Forecast

Analysts have given TVGN a Strong Buy based on their latest research and market trends.

According to 1 analysts, TVGN has a Strong Buy consensus rating as of Apr 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Semper Paratus Acquisition Corp (TVGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.